HIV Citation List: October 28, 2011 - November 10, 2011

Pubmed citations

1. 1,3-dihydro-2H-indol-2-ones Derivatives: Design, Synthesis, in vitro Antibacterial, Antifungal and Antitubercular Study. Akhaja, T.N. and J.P. Raval, European Journal of Medicinal Chemistry, 2011. 46(11): p. 5573-5579; PMID[21981980].
[PubMed]. HIV_1028-111011.

2. Design, Synthesis, and Functionalization of Dimeric Peptides Targeting Chemokine Receptor CXCR4. Demmer, O., I. Dijkgraaf, U. Schumacher, L. Marinelli, S. Cosconati, E. Gourni, H.J. Wester, and H. Kessler, Journal of Medicinal Chemistry, 2011. 54(21): p. 7648-7662; PMID[21905730].
[PubMed]. HIV_1028-111011.

3. Combining Symmetry Elements Results in Potent Naphthyridinone (NTD) HIV-1 Integrase Inhibitors. Johns, B.A., T. Kawasuji, J.G. Weatherhead, E.E. Boros, J.B. Thompson, E.P. Garvey, S.A. Foster, J.L. Jeffrey, W.H. Miller, N. Kurose, K. Matsumura, and T. Fujiwara. Bioorganic & Medicinal Chemistry Letters, 2011. 21(21): p. 6461-6464; PMID[21945283].
[PubMed]. HIV_1028-111011.

4. Molecular Dynamics Approaches Estimate the Binding Energy of HIV-1 Integrase Inhibitors and Correlate with in vitro Activity. Johnson, B.C., M. Metifiot, Y. Pommier, and S.H. Hughes, Antimicrobial Agents and Chemotherapy, 2011. [Epub ahead of print]; PMID[22037850].
[PubMed]. HIV_1028-111011.

5. Synthesis of Novel Difluoro-cyclopropyl Guanine Nucleosides and their Phosphonate Analogues as Potent Antiviral Agents. Li, H., J.C. Yoo, E. Kim, and J.H. Hong, Nucleosides Nucleotides Nucleic Acids, 2011. 30(11): p. 945-960; PMID[22060557].
[PubMed]. HIV_1028-111011.

6. F18, a Novel Small Molecule NNRTI, Inhibits HIV-1 Replication Using Distinct Binding Motifs as Demonstrated by Resistance Selection and Docking Analysis. Lu, X., L. Liu, X. Zhang, T.C. Lau, S.K. Tsui, Y. Kang, P. Zheng, B. Zheng, G. Liu, and Z. Chen, Antimicrobial Agents and Chemotherapy, 2011. [Epub ahead of print]; PMID[22037848].
[PubMed]. HIV_1028-111011.

7. Inhibition of HIV-1 by Octadecyloxyethyl Esters of (S)-[3-Hydroxy-2-(Phosphonomethoxy)Propyl] Nucleosides and Evaluation of Their Mechanism of Action. Magee, W.C., N. Valiaeva, J.R. Beadle, D.D. Richman, K.Y. Hostetler, and D.H. Evans, Antimicrobial Agents and Chemotherapy, 2011. 55(11): p. 5063-5072; PMID[21896914].
[PubMed]. HIV_1028-111011.

8. HIV-1 Integrase Inhibitor T30177 Forms a Stacked Dimeric G-quadruplex Structure Containing Bulges. Mukundan, V.T., N.Q. Do, and A.T. Phan, Nucleic Acids Research, 2011. 39(20): p. 8984-8991; PMID[21771859].
[PubMed]. HIV_1028-111011.

9. Comparative Antiviral Activity of Integrase Inhibitors in Human Monocyte-derived Macrophages and Lymphocytes. Scopelliti, F., M. Pollicita, F. Ceccherini-Silberstein, F. Di Santo, M. Surdo, S. Aquaro, and C.F. Perno, Antiviral Research, 2011. 92(2): p. 255-261; PMID[21867733].
[PubMed]. HIV_1028-111011.

10. Galectin-1 Specific Inhibitors as a New Class of Compounds to Treat HIV-1 Infection. St-Pierre, C., M. Ouellet, D. Giguere, R. Ohtake, R. Roy, S. Sato, and M.J. Tremblay, Antimicrobial Agents and Chemotherapy, 2011. [Epub ahead of print]; PMID[22064534].
[PubMed]. HIV_1028-111011.

11. An Optimized MM/PBSA Virtual Screening Approach Applied to an HIV-1 gp41 Fusion Peptide Inhibitor. Venken, T., D. Krnavek, J. Munch, F. Kirchhoff, P. Henklein, M. De Maeyer, and A. Voet, Proteins, 2011. 79(11): p. 3221-3235; PMID[21989940].
[PubMed]. HIV_1028-111011.

12. In vitro Phenotypic Susceptibility of HIV-2 Clinical Isolates to CCR5 Inhibitors. Visseaux, B., C. Charpentier, M. Hurtado-Nedelec, A. Storto, R. Antoine, G. Peytavin, F. Damond, S. Matheron, F. Brun-Vezinet, and D. Descamps, Antimicrobial Agents and Chemotherapy, 2011. [Epub ahead of print]; PMID[22064539].
[PubMed]. HIV_1028-111011.

13. Development of Dual-Acting Pyrimidinediones as Novel and Highly Potent Topical Anti-HIV Microbicides. Watson Buckheit, K., L. Yang, and R.W. Buckheit, Jr., Antimicrobial Agents and Chemotherapy, 2011. 55(11): p. 5243-5254; PMID[21896906].
[PubMed]. HIV_1028-111011.

14. A Novel Ribonuclease with Potent HIV-1 Reverse Transcriptase Inhibitory Activity from Cultured Mushroom Schizophyllum Commune. Zhao, Y.C., G.Q. Zhang, T.B. Ng, and H.X. Wang, Journal of Microbiology, 2011. 49(5): p. 803-808; PMID[22068498].
[PubMed]. HIV_1028-111011.

ISI Web of Knowledge citations

15. Extensive Profile of the Anti-HIV Inhibitory Activity of Well-Known Monoclonal Antibodies, Possible Correlates for In Vivo Protection. Biedma, M.S., S Decoville, T Laumond, G Holl, V Moog, C, Aids Research and Human Retroviruses, 2011. 27(10): p. A48-A48; ISI[000295790500117].
[WOS]. HIV_1028-111011.

16. Variability of a diterpene with potential anti-HIV activity isolated from the Brazilian brown alga Dictyota menstrualis. Cavalcanti, D.d.O., MAR De-Paula, JC Barbosa, LS Fogel, T Pinto, MA Paixao, ICND Teixeira, VL, Journal of Applied Phycology, 2011. 23(5): p. 873-876; ISI[000295822300010]. [WOS]. HIV_1028-111011.

17. Synthesis of Quinolin-2-one Alkaloid Derivatives and Their Inhibitory Activities against HIV-1 Reverse Transcriptase. Cheng, P.G., Q Liu, W Zou, JF Ou, YY Luo, ZY Zeng, JG, Molecules, 2011. 16(9): p. 7649-7661; ISI[000295211000035].
[WOS]. HIV_1028-111011.

18. Zidovudine (AZT) has a bactericidal effect on enterobacteria and induces genetic modifications in resistant strains European. Doleans-Jordheim, A.B., E Bereyziat, F Ben-Larbi, S Dumitrescu, O Mazoyer, MA Morfin, F Dumontet, C Freney, J Jordheim, LP, Journal of Clinical Microbiology & Infectious Diseases, 2011. 30(10): p. 1249-1256; ISI[000295864600017].
[WOS]. HIV_1028-111011.

19. Synthesis and biological evaluation of new 3,5-di(trifluoromethyl)-1,2,4-triazolesulfonylurea and thiourea derivatives as antidiabetic and antimicrobial agents. Faidallah, H.K., KA Asiri, AM, Journal of Fluorine Chemistry, 2011. 132(11): p. 870-877; ISI[000295911100002].
[WOS]. HIV_1028-111011.

20. Isolation and identification of alkaloids of Erythrina abyssinica A Sudanese medicinal plant.. Gagdim, A. and A. Musa, Clinical Biochemistry, 2011. 44(13): p. S40-S40; ISI[000295437600116].
[WOS]. HIV_1028-111011.

21. A novel and efficient one-pot synthesis of symmetrical diamide (bis-amidate) prodrugs of acyclic nucleoside phosphonates and evaluation of their biological activities. Jansa, P., O. Baszczynski, M. Dracinsky, I. Votruba, Z. Zidek, G. Bahador, G. Stepan, T. Cihlar, R. Mackman, A. Holy, and Z. Janeba, European Journal of Medicinal Chemistry, 2011. 46(9): p. 3748-3754; ISI[000295237400022]. [WOS]. HIV_1028-111011.

22. Total syntheses of (+)- and (-)-1,3,4,5-tetragalloylapiitol and revision of absolute configuration of naturally occurring (-)-1,3,4,5-tetragalloylapiitol. Kojima, M., Y. Nakamura, S. Akai, K.I. Sato, and S. Takeuchi, Tetrahedron, 2011. 67(43): p. 8293-8299; ISI[000295662600010].
[WOS]. HIV_1028-111011.

23. Synthesis of enantiopure beta-amino alcohols via AKR/ARO of epoxides using recyclable macrocyclic Cr(III) salen complexes.Kureshy, R.P., KJ Kumar, M Bera, PK Khan, NUH Abdi, SHR Bajaj, HC, Tetrahedron, 2011. 67(43): p. 8300-8307; ISI[000295662600011].
[WOS]. HIV_1028-111011.

24. Synthesis and biological activity of 4-chloro-2-hydroxy-N-(5-methylene-4-oxo-2-aryl-thiazolidin-3-yl) benzamide. Maheta, S. and S.J. Patel, Bulgarian Chemical Communications, 2011. 43(3): p. 411-418; ISI[000295710100008].
[WOS]. HIV_1028-111011.

25. Synthesis and structural studies of pentacycloundecane-based HIV-1 PR inhibitors: A hybrid 2D NMR and docking/QM/MM/MD approach. Makatini, M.P., K Sriharsha, SN Ndlovu, N Soliman, MES Honarparvar, B Parboosing, R Naidoo, A Arvidsson, PI Sayed, Y Govender, P Maguire, GEM Kruger, HG Govender, T, European Journal of Medicinal Chemistry, 2011. 46(9): p. 3976-3985; ISI[000295237400046].
[WOS]. HIV_1028-111011.

26. Recombinant production of anti-HIV protein, Griffithsin, in E. coli. Mohammad, A.Y., V Mesbah, B Houshang, A, Clinical Biochemistry, 2011. 44(13): p. S349-S349; ISI[000295437601518].
[WOS]. HIV_1028-111011.

27. Synthesis and identification of beta-aryloxyquinolines and their pyrano[3,2-c] chromene derivatives as a new class of antimicrobial and antituberculosis agents. Mungra, D.C., M.R. Patel, D.P. Rajani, and R.G. Patel, European Journal of Medicinal Chemistry, 2011. 46(9): p. 4192-4200; ISI[000295237400069].
[WOS]. HIV_1028-111011.

28. Computational analysis of aspartic protease plasmepsin II complexed with EH58 inhibitor: a QM/MM MD study. Silva, N.D., J. Lameira, and C.N. Alves, Journal of Molecular Modeling, 2011. 17(10): p. 2631-2638; ISI[000295940700020].
[WOS]. HIV_1028-111011.

29. Synthesis and antiviral evaluation of alpha-L-2 '-deoxythreofuranosyl nucleosides. Toti, K.S., M. Derudas, C. McGuigan, J. Balzarini, and S. Van Calenbergh, European Journal of Medicinal Chemistry, 2011. 46(9): p. 3704-3713; ISI[000295237400018].
[WOS]. HIV_1028-111011.

30. Synthesis and in vitro Study of Antiviral and Virucidal Activity of Novel 2-[(4-Methyl-4H-1,2,4-triazol-3-yl)sulfanyl]acetamide Derivatives. Wujec, M.P., T Siwek, A Rajtar, B Polz-Dacewicz, M, Zeitschrift fur Naturforschung Section C-A Journal of Biosciences, 2011. 66(7-8): p. 333-339; ISI[000295498600003].
[WOS]. HIV_1028-111011.

31. Identification of a nonpeptide cyclic urea inhibitor of HIV protease using in silico molecular docking. Yazdani, M. and M. Masomi, Clinical Biochemistry, 2011. 44(13): p. S321-S322; ISI[000295437601432].
[WOS]. HIV_1028-111011.

32. Synthesis, antiviral activity, cytotoxicity and cellular pharmacology of L-3 '-azido-2 ',3 '-dideoxypurine nucleosides. Zhang, H.D., M Herman, BD Solomon, S Bassit, L Nettles, JH Obikhod, A Tao, SJ Mellors, JW Sluis-Cremer, N Coats, SJ Schinazi, RF, European Journal of Medicinal Chemistry, 2011. 46(9): p. 3832-3844; ISI[000295237400031].
[WOS]. HIV_1028-111011.